It is a pharma private limited company based in Belapur, Maharashtra, India, established in 2011.
2011 | Belapur, Maharashtra, India | ActiveSmega Pharmaceuticals Private Limited, a active private limited company, was established on 14 November 2011 in Belapur, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U51909MH2011PTC223917. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.20 M and a paid-up capital of ₹0.14 M.
It upholds a compliant status. Its leadership includes Gautam Kumar Aniruddha Das (Director), Madhav Gaikwad Tulsiram (Director), Nilesh Laxman Gajmal (Director). Past directors included Gautam Kumar Aniruddha Das, Sumedh Gaikwad Madhav. It holds ₹4.00 M open charges and no settled loans. Its latest AGM occurred on 27 September 2019, with the balance sheet filed on 31 March 2019. It is based at Office No.607, 6Th Floor, A-Wing Hermes Antrium Plot No.57, Sec-11,, Belapur, Maharashtra, 400614.
U51909MH2011PTC223917
223917
14 November 2011
₹0.20 M
₹0.14 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Smega Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Gautam Kumar Aniruddha Das | Director | 14 Nov 2011 | Current |
| Madhav Gaikwad Tulsiram | Director | 10 Jan 2017 | Current |
| Nilesh Laxman Gajmal | Director | 27 Dec 2016 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 30 Sep 2021 | Past |
| Pramod Abcsdd | Director | 10 Jan 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Smega Pharmaceuticals Private Limited, for the financial year ended 2019, experienced significant reduction in revenue, with a 41.23% decrease. The company also saw a substantial fall in profitability, with a 21120.74% decrease in profit. The company's net worth observed a substantial decline by a decrease of 19.94%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Smega Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹4,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Jan 2015 | State Bank Of Hyderabad | ₹4.00 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Smega Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Smega Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Smega Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Smega Pharmaceuticals Private Limited last Annual general meeting of members was held on 27 Sep 2019 as per latest MCA records. was recorded as a recent event.
Smega Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Mumbai. was recorded as a recent event.
Madhav Gaikwad Tulsiram was appointed as a Director was appointed as a Director on 10 Jan 2017 & has been associated with this company since 8 years 10 months . was recorded as a recent event.
Progress on Nilesh Laxman Gajmal was appointed as a Director was appointed as a Director on 27 Dec 2016 & has been associated with this company since 8 years 11 months . was documented.
A charge with State Bank Of Hyderabad amounted to Rs. 4.00 M with Charge ID 10549124 was registered on 20 Jan 2015. was recorded as a recent event.
Gautam Kumar Aniruddha Das was appointed as a Director was appointed as a Director on 14 Nov 2011 & has been associated with this company since 14 years 17 days . was recorded as a recent event.
The CIN of Smega Pharmaceuticals Private Limited is U51909MH2011PTC223917.
Smega Pharmaceuticals Private Limited is headquartered at Office No.607, 6Th Floor, A-Wing Hermes Antrium Plot No.57, Sec-11,, Belapur, Maharashtra, 400614.
Smega Pharmaceuticals Private Limited was incorporated on 14 November 2011.
The current directors of Smega Pharmaceuticals Private Limited are
The primary industry of Smega Pharmaceuticals Private Limited is Trade.
Smega Pharmaceuticals Private Limited is unlisted.
The authorized capital of Smega Pharmaceuticals Private Limited is ₹0.20 M, and the paid-up capital is ₹0.14 M.
The compliance status of Smega Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX